- ￥6903 - 23985
- Biorbyt
- orb2957008
- 英国
- 2026年08月07日
- ELISA, NeA
- Human
- Virus
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
香烟烟雾如何加速声带纤维化？CD44-透明质酸轴是关键通路Takara 秋促来袭，提取+反转录+定量套装仅 1200 元五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
SARS-CoV-2 RBD (JN.1) Neutralizing Human Monoclonal Antibody 抗体
- 抗体英文名：
SARS-CoV-2 RBD (JN.1) Neutralizing Human Monoclonal Antibody
- 浓度：
Lot dependent
- 应用范围：
ELISA, NeA
- 宿主：
Human
- 适应物种：
Virus
- 保质期：
12 months from date of receipt.
- 抗原来源：
详询
- 目录编号：
orb2957008
- 级别：
科研
- 库存：
99
- 供应商：
Biorbyt
- 标记物：
Unconjugated
- 克隆性：
Monoclonal
- 保存条件：
详询
- 形态：
Liquid
- 亚型：
IgG1, kappa
- 免疫原：
详询
- 规格：
100 ug/1 mg
| 规格： | 100 ug | 产品价格： | ￥6903.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥23985.0 |
产品子类型: Recombinant Antibody
描述: SARS-CoV-2 RBD (JN.1) Neutralizing Human Monoclonal Antibody is an unconjugated monoclonal antibody. It shows reactivity with Virus samples. It is suitable for use in ELISA, NeA applications. The antibody is supplied in liquid form. It is Protein A/G purified from cell culture supernatant. Purity is >95% as determined by SDS-PAGE.
克隆号: BKX2444
别名: Spike glycoprotein, S glycoprotein, Spike protein S1, Receptor-Binding Domain, RBD, JN.1, SARS-CoV-2 (2019-nCoV)
内毒素: Please contact with the lab for this information.
防腐剂: 0.01M PBS, pH 7.4.
纯度: >95% as determined by SDS-PAGE.
纯化方法: Protein A/G purified from cell culture supernatant.
研究领域: Infectious Disease & Virology
UniProt ID: P0DTC2
保存条件: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
备注: For research use only.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验for gp41 in the context of the whole Env we developed a methodology termed competitive antigen panning (CAP). Using CAP, we identified a panel of gp41-specific human monoclonal antibodies from an HIV-1 immune library derived from long-term nonprogressors
中科院高福院士课题组 2020 年发表了哪些重要的研究成果？
：Science 9、Science 后再发 Nature！筛选出又一新冠病毒治疗性单克隆中和抗体DOI: 10.1038/s41586-020-2381-y继之前发表在 Science 上报道筛选出新冠病毒中和抗体后，2020 年 5 月 26 日，高福院士再次联合严景华等人在 Nature 发文：A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2。该研究报告了从 COVID-19 恢复期的患者中分离出两
Antibody Fragment Expression and Purification
Interest in the potential of monoclonal antibodies (mAbs) to serve as therapeutic agents has surged in the past decade with a major emphasis on human viral diseases. There has been much attention in this area directed towards the human
技术资料暂无技术资料 索取技术资料
